Method of administering EDTA complexes

Details Method of administering EDTA complexes Method of administering EDTA complexes

1995-03-31

1997-02-11

Nutter, Nathan M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

514964, 424457, 424DIG15, A01N 3700, A01J 2512

Patent

active

056021801

ABSTRACT:
A method of administering EDTA complexes includes steps of forming a suppository containing an EDTA complex and controlled-release agents which release the EDTA complex over a period of about three to four hours after placement, and then administering the suppository to a patient in lieu of an intravenous drip.

REFERENCES:
patent: 4107331 (1978-08-01), Rosenberg
patent: 5208324 (1993-05-01), Klaveness et al.
patent: 5281704 (1994-01-01), Love et al.

Affiliated with

Also associated with

Rating

Method of administering EDTA complexes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of administering EDTA complexes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of administering EDTA complexes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-342694